Atlas Trials

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Clinical trial NCT00830336 · COMPLETED

Trial details

NCT number
NCT00830336
Sponsor
Teva Pharmaceuticals USA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2005-10-01
Primary completion
2005-11-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.